Navigation Links
Cancer Patients Protest For Free Drug Treatment

Margaret Bradford, from Oswestry, a patient with breast cancer in England has started a protest after news that patients in Welsh are given free drug treatment// at a hospital. Local health boards in Wales fund treatment for Herceptin in full, unlike the Shropshire Primary Care Trust. The patients in Shropshire have to pay an amount of £47,000 bill is staging a protest at the hospital on Monday.

North Shropshire MP Owen Paterson said that breast cancer patients from Wales are getting the potentially life-saving drug free at a hospital while their English patients have to pay. Welsh women do not have to pay for Herceptin at the Royal Shrewsbury Hospital, which provides acute care for people in north Shropshire and mid-Wales, because it is funded by their local health board. But patients in the early stages of the illness who live over the border must pay £47,000 themselves because their primary care trust will not foot the bill, Owen Paterson, said.

Stating that the situation was a "classic postcode lottery" Mr Paterson said that he would contact Health Secretary Patricia Hewitt to express his disgust. He said that all these women in Shropshire too have paid their taxes but yet they have to raise huge sums of money for treatment while women from two miles away in Wales are getting the drug in the same hospital for free. The 544-bed Royal Shrewsbury Hospital provides acute care for people in north Shropshire and mid Wales. Health Secretary Patricia Hewitt has meanwhile urged the primary care trusts (PCT) not refuse Herceptin treatment on the basis of cost.

A group of cancer patients from Shropshire have said they intend to take their fight to be given Herceptin to the European courts. Certain health authorities have approved funding for the treatment of early stage cancer, while others have not. The Shropshire PCT claims to be waiting for the drug to be licensed for treating, early stage breast cancer before it approves funding. A W elsh Assembly spokesman said Herceptin was available as a case-by-case basis on the NHS if a doctor believed that the patient would benefit from it.

Since February, all Welsh local health boards have agreed to pay for the drug for women living in Wales, even if they are treated in England, if their doctor recommends it and they meet the clinical prescribing guidelines for Herceptin.

'"/>




Related medicine news :

1. Fibroids unlikely to Turn Cancerous
2. Virus Level could Predict Cervical Cancer Risk
3. Cancer Doctors Okays Controversial Prostate Therapy
4. Potential New Cancer Gene Identified
5. Consensus on "Combination Therapy" for Breast Cancer
6. Cancers of Colon & Rectum linked to Cigarette Smoking
7. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
8. The Cancer Rumour mill working over time
9. Cancer drugs in development nearly doubled since 1995
10. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
11. Cancer patients turning to Internet for information
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/21/2017)... ... July 21, 2017 , ... MedMatchPlus+ has ... chances of acceptance to a residency in a United States hospital. Being accepted ... the U.S. , According to data released by the ECFMG®, every year, 50 ...
(Date:7/21/2017)... ... July 21, 2017 , ... Sharon ... the signature product of her research center at Bio-Logic Aqua Research® Water Life ... and the greatest number of sufferers of blindness. “We think that Nature’s Tears® ...
(Date:7/21/2017)... ... July 21, 2017 , ... In the ... from the Multicenter Orthopaedics Outcome Network (MOON) demonstrated that patients could perform sports-related ... though activity levels decline over time. The study, presented today at the ...
(Date:7/21/2017)... ONTARIO, CANADA (PRWEB) , ... July 21, 2017 ... ... give insight into why concussion rates are on the rise, say researchers presenting ... Meeting today in Toronto, Ontario, Canada. , “The combination of evaluating the patterns ...
(Date:7/20/2017)... ... 2017 , ... ChenMed , a leading provider of value-based care for ... as Richmond Chief Medical Officer. Dr. McCarter, formerly Associate Professor of Family ... of Ambulatory Services for the UVA Health System, brings 30 years of highly relevant ...
Breaking Medicine News(10 mins):
(Date:7/21/2017)... RESEARCH TRIANGLE PARK, N.C. , July ... UTHR ) announced today that it will report ... opens on Thursday, July 27, 2017. ... on Thursday, July 27, 2017, at 9:00 a.m. Eastern ... international callers dialing 1-970-315-0533.  A rebroadcast of the teleconference ...
(Date:7/20/2017)... -- Prime Therapeutics LLC (Prime) released this statement from its Chief ... for Clinical and Economic Review,s (ICER) public meeting ... of abuse-deterrent formulations (ADF) of opioids. Prime was the sole ... "The ICER data ... use of abuse-deterrent formulations (ADF) in opioids in terms of ...
(Date:7/15/2017)... Enterin Inc., a Philadelphia -based ... today announced the completion of a $12.7 million Series A ... as well as the participation of existing investors. ... the support of New Ventures III and our current investors, ... the potential of our platform technology to transform the course ...
Breaking Medicine Technology: